Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor–Positive/HER2-Negative Advanced or Metastatic Breast Cancer
Article in Clinical Cancer Research (April 2021)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Clinical Cancer Research (April 2021)
Article in Oncology in Clinical Practice (November 2018)
Article in Current Breast Cancer Reports (November 2018)